reader comments 29 with Share this story Vaccine maker Moderna has forked over $400 million to the National Institutes of Health for using a molecular stabilizing technique borrowed from government and academic researchers in its mRNA-based COVID-19 vaccine—which the company made roughly $36 billion selling amid the deadly pandemic, according to The New York Times. ..
Tag : moderna
Enlarge / The Comirnaty (Pfizer/BioNTech) and Moderna COVID-19 vaccines. reader comments 511 with Share this story Two Republican lawmakers in Idaho have introduced a bill that would make it a misdemeanor for anyone in the state to administer mRNA-based vaccines—namely the lifesaving and remarkably safe COVID-19 vaccines made by Pfizer-BioNTech and Moderna. If passed as ..
Enlarge / Moderna CEO Stephane Bancel during a Bloomberg Television interview on the closing day of the World Economic Forum in Davos, Switzerland, on May 26, 2022. reader comments 214 with 0 posters participating Share this story Moderna is considering raising the price of its COVID-19 vaccine by over 400 percent—from $26 per dose to ..
Enlarge / Reisa Lancaster RN, left, administers the Covid-19 vaccine to 14 month old Ada Hedge, center, being comforted by mom Sarah Close and dad Chinmay Hedge, right at Children’s National Research and Innovation Campus, in Washington, DC. reader comments 28 with 0 posters participating Share this story The Food and Drug Administration has greenlit ..
Enlarge / A pharmacist prepares to administer COVID-19 vaccine booster shots during an event hosted by the Chicago Department of Public Health at the Southwest Senior Center on September 9 in Chicago. The recently authorized booster vaccine protects against the original SARS-CoV-2 virus and the more recent omicron variants, BA.4 and BA.5. reader comments 58 ..
Enlarge / Moderna states that it doesn’t want to halt production or distribution of Pfizer/BioNTech’s vaccine, but it does want to be paid a license for its claimed patents. Getty Images reader comments 41 with 34 posters participating Share this story Now that the vaccine race is over and shots are broadly available, Moderna has ..
Enlarge / Dr. Peter Marks, director of the Center for Biologics Evaluation and Research within the Food and Drug Administration, testifies during a Senate Health, Education, Labor, and Pensions Committee hearing on the federal coronavirus response on Capitol Hill on March 18, 2021, in Washington, DC. reader comments 105 with 69 posters participating Share this ..
Enlarge / Boston Medical Center Child Life Specialist Karlie Bittrich sees to a baby while in a pediatrics tent set up outside of Boston Medical Center in Boston on April 29, 2020. reader comments 126 with 63 posters participating Share this story A committee of experts advising the Food and Drug Administration voiced unanimous support ..
Enlarge / A vial of the current Moderna COVID-19 vaccine. reader comments 58 with 39 posters participating Share this story A combination COVID-19 booster dose that targets the ancestral strain of SARS-CoV-2 and the initial omicron variant, BA.1, appears to outperform the current booster against both of those versions of the virus, Moderna reported Wednesday. ..
Enlarge / The Comirnaty (Pfizer/BioNTech) and Moderna COVID-19 vaccines. reader comments 67 with 50 posters participating Share this story Covid-19 Coverage View more stories People ages 60 and older who were initially vaccinated with two Pfizer-BioNTech COVID-19 vaccine doses were better protected from the omicron coronavirus variant after being boosted with a Moderna vaccine rather ..